Nkarta, Inc. (NKTX)
2.92
+0.13
(+4.66%)
USD |
NASDAQ |
Sep 04, 16:00
2.91
-0.01
(-0.34%)
After-Hours: 20:00
Nkarta Cash and Short Term Investments (Annual) : 276.28M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 276.28M |
| December 31, 2024 | 267.35M |
| December 31, 2023 | 248.19M |
| December 31, 2022 | 352.14M |
| Date | Value |
|---|---|
| December 31, 2021 | 238.09M |
| December 31, 2020 | 314.91M |
| December 31, 2019 | 36.99M |
| December 31, 2018 | 7.867M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 215.46M |
| Theriva Biologics, Inc. | 13.06M |
| Yarrow Bioscience, Inc. | 29.01M |
| Unicycive Therapeutics, Inc. | 41.27M |
| OnKure Therapeutics, Inc. | 59.05M |